Swiss National Bank’s Albireo Pharma Inc ALBO Stock Holding History

Swiss National Bank’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-42,600	Closed	-$921K	–	2694
2022 Q4	$921K	Buy	42,600 +1,700	+4%	+$35.9K	﹤0.01%	2388
2022 Q3	$792K	Hold	40,900	–	–	﹤0.01%	2427
2022 Q2	$812K	Buy	40,900 +2,100	+5%	+$55.4K	﹤0.01%	2469
2022 Q1	$1.16M	Buy	38,800 +2,800	+8%	+$82K	﹤0.01%	2337
2021 Q4	$838K	Buy	36,000 +2,300	+7%	+$61.1K	﹤0.01%	2537
2021 Q3	$1.05M	Hold	33,700	–	–	﹤0.01%	2417
2021 Q2	$1.19M	Sell	33,700 -1,200	-3%	-$39K	﹤0.01%	2407
2021 Q1	$1.23M	Buy	34,900 +600	+2%	+$22.2K	﹤0.01%	2272
2020 Q4	$1.29M	Buy	+34,300	New	+$1.25M	﹤0.01%	2169

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Swiss National Bank's ALBO Position: Q1 2023 in Review

Swiss National Bank sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 42,600 shares — an estimated $921K sold.

Swiss National Bank first reported a position in ALBO in Q4 2020 and held it in 9 quarters. The position peaked at $1.29M in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Swiss National Bank reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Swiss National Bank sold 42,600 Albireo Pharma Inc shares in Q1 2023, an estimated $921K.
Swiss National Bank first reported a position in Albireo Pharma Inc in Q4 2020 and held it in 9 quarters.
Swiss National Bank's Albireo Pharma Inc position peaked at $1.29M in Q4 2020.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.